Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (30)
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,900
Price
$0.92
Total Value
$1.75K
Shares Held After
375,785
% of Holdings
0.5%
Altimmune, Inc. (ALT)
Durso Jerome Benedict — Director
Shares
15,000
Price
$2.95
Total Value
$44.25K
Shares Held After
62,500
% of Holdings
24.0%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
460,000
Price
$0.64
Total Value
$292.10K
Shares Held After
1,343,886
% of Holdings
34.2%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,220
Price
$0.32
Total Value
$710.40
Shares Held After
34,199
% of Holdings
6.5%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
2,600
Price
$9.63
Total Value
$25.04K
Shares Held After
77,900
% of Holdings
3.3%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
1,462
Price
$13.19
Total Value
$19.28K
Shares Held After
1,544,980
% of Holdings
0.1%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
3,500
Price
$8.62
Total Value
$30.17K
Shares Held After
83,500
% of Holdings
4.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
34,000
Price
$8.62
Total Value
$293.05K
Shares Held After
790,000
% of Holdings
4.3%
Korro Bio, Inc. (KRRO)
Lynx1 Capital Management LP — 10% Owner
Shares
5,222
Price
$11.40
Total Value
$59.53K
Shares Held After
1,543,518
% of Holdings
0.3%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
685
Price
$0.22
Total Value
$150.70
Shares Held After
31,979
% of Holdings
2.1%
ProMIS Neurosciences Inc. (PMN)
Kaplan Johanne — Chief Development Officer
Shares
2,280
Price
$13.30
Total Value
$30.32K
Shares Held After
6,221
% of Holdings
36.7%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
5,000
Price
$0.26
Total Value
$1.29K
Shares Held After
31,294
% of Holdings
16.0%
Adagene Inc. (ADAG)
Luo Peter — Director
Shares
279
Price
$3.65
Total Value
$1.02K
Shares Held After
68,245
% of Holdings
0.4%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
10,000
Price
$0.98
Total Value
$9.82K
Shares Held After
1,993,551
% of Holdings
0.5%
Tiziana Life Sciences Ltd (TLSA)
Elrifi Ivor — Chief Executive Officer
Shares
237,616
Price
$1.00
Total Value
$237.62K
Shares Held After
4,793,684
% of Holdings
5.0%
Adagene Inc. (ADAG)
Luo Peter — Director
Shares
22,966
Price
$3.65
Total Value
$83.75K
Shares Held After
67,966
% of Holdings
33.8%
Tiziana Life Sciences Ltd (TLSA)
Elrifi Ivor — Chief Executive Officer
Shares
83,807
Price
$0.97
Total Value
$81.29K
Shares Held After
4,556,068
% of Holdings
1.8%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
800,000
Price
$0.50
Total Value
$400.00K
Shares Held After
883,886
% of Holdings
90.5%
Hepion Pharmaceuticals, Inc. (HEPA)
Appajosyula Sireesh — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
16,250,000
% of Holdings
12.3%
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
8,000,000
Price
$0.05
Total Value
$400.00K
Shares Held After
14,250,000
% of Holdings
56.1%
Hepion Pharmaceuticals, Inc. (HEPA)
Purcell Michael J. — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. II — Director
Shares
500,000
Price
$0.05
Total Value
$25.00K
Shares Held After
500,000
% of Holdings
100.0%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. — Director
Shares
2,000,000
Price
$0.05
Total Value
$100.00K
Shares Held After
3,250,000
% of Holdings
61.5%
Camp4 Therapeutics Corp (CAMP)
Maricich Yuri — Chief Medical Officer
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
12,611
% of Holdings
51.9%
Camp4 Therapeutics Corp (CAMP)
Young Richard A — Director
Shares
16,378
Price
$1.65
Total Value
$27.02K
Shares Held After
186,388
% of Holdings
8.8%
Camp4 Therapeutics Corp (CAMP)
Gold Kelly — Chief Financial Officer
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
74,428
% of Holdings
8.8%
Camp4 Therapeutics Corp (CAMP)
Mandel-Brehm Josh — Director
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
284,968
% of Holdings
2.3%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
75,000
Price
$0.94
Total Value
$70.59K
Shares Held After
1,983,551
% of Holdings
3.8%
Tiziana Life Sciences Ltd (TLSA)
Elrifi Ivor — Chief Executive Officer
Shares
667,000
Price
$1.00
Total Value
$667.00K
Shares Held After
4,472,261
% of Holdings
14.9%
Showing 1–30 of 30 transactions (page 1 of 1)